Allianz Asset Management GmbH
Position in AUPH — Aurinia Pharmaceuticals Inc.
CIK 1535323
MUNICH, 2M
Position in AUPH
as of Jun 30, 2026
· filed Sep 2, 2026
Position Value
$14,284,175
+$14,010,536 QoQ
Shares Held
841,731
+6934.9% QoQ
Ownership
0.633%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#20
of 282 holders
Holding Since
Mar 2020
7 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in AUPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Allianz Asset Management GmbH holds $783,743,061 across 80 Biotechnology names. AUPH ranks #13 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
380,618 | $237,330,545 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
545,071 | $131,345,757 | |
| 3 | MRNA |
Moderna, Inc.
|
984,497 | $68,944,324 | |
| 4 | EXEL |
Exelixis, Inc.
|
666,268 | $36,251,640 | |
| 5 | INCY |
Incyte Corp
|
229,921 | $26,063,844 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
418,602 | $23,952,406 | |
| 7 | 177,000 | $23,493,210 | |||
| 8 | FTRE |
Fortrea Holdings Inc.
|
1,141,537 | $19,862,743 |
All Filings in AUPH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,284,175 | 841,731 | Shares | Defined | 2026-09-02 | |
| 2021-12-31 | $273,639 | 11,965 | Shares | Defined | 2022-02-11 | |
| 2021-03-31 | $431,426 | 33,225 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $2,895,614 | 209,372 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $3,130,743 | 212,542 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,990,268 | 245,555 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,413,695 | 235,265 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||